Company / Current Assets per Share
SAB Biotherapeutics, Inc. Current Assets per Share History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$10.88
FY2025
5-year range
$1.33 / $11.69
FY2021-FY2025
Trend
+321.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Assets per Share changed +322% YoY in FY2025, a notable deviation from the 4-year average annual change of +199%.
Based on SEC 10-K filings.
10.88 in FY2025 with a 3-year CAGR of +77.9%.
Declined from $11.69 to $10.88 over the past 2 years.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- +77.9%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, current assets per share increased 321.8% year-over-year.
- Peak current assets per share was recorded in FY2023.
- Lowest current assets per share in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.31 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $10.88 | +321.8% |
| FY2024 | $2.58 | -77.9% |
| FY2023 | $11.69 | +504.8% |
| FY2022 | $1.93 | +45.7% |
| FY2021 | $1.33 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026